This CPD activity provides an evidence-based review of the pharmacological properties, mechanism of action, and clinical outcomes associated with fexofenadine in the management of allergic rhinitis and chronic urticaria.
Drawing on published clinical data and long-term experience, the activity explores the role of H₁-receptor inverse agonism, anti-inflammatory effects, efficacy outcomes, safety, and tolerability.
Emphasis is placed on clinical decision-making, appropriate patient selection, and the impact of antihistamine therapy on symptom control, daily functioning, and quality of life.
The content is designed to support healthcare professionals in applying current evidence to routine clinical practice.
Learning Outcomes:
- Describe the mechanism of action of fexofenadine, including its role as an H₁-receptor inverse agonist and its additional anti-inflammatory effects.
- Summarise key clinical evidence supporting the efficacy of fexofenadine in allergic rhinitis, including onset of action, symptom control, and impact on quality of life.
- Discuss the safety and tolerability profile of fexofenadine, with particular reference to sedation, cognitive performance, and use across different patient populations.
- Evaluate the clinical evidence supporting the use of fexofenadine in the management of chronic urticaria, including effects on pruritus and wheal formation.
- Apply evidence-based principles to the selection of antihistamine therapy in patients requiring effective symptom relief without impairment of alertness or daily functioning.
The CPD questions are based on insights from the presentation you attended, as well as a referenced journal article provided for additional reading. To complete the CPD activity, please answer the multiple-choice questions; each with only one correct answer. You have a maximum of three attempts. Successful completion will earn you 3 clinical CEUs.
To get started, simply click the “LET’S GO!” button located just above the banner, and follow the link to access the CPD questionnaire
You need to be registered and logged in to be able to access and submit the question below.